Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Virtu explores sale of brokerage unit valued at over $3.5B

Virtu explores sale of brokerage unit valued at over $3.5B

CryptobriefingCryptobriefing2026/08/20 15:21
By:Cryptobriefing

Virtu Financial is quietly shopping its brokerage division, with the unit carrying a price tag north of $3.5B. Some valuations have pushed the figure closer to $4B, which would represent a remarkable return on a business Virtu assembled largely through a single acquisition less than a decade ago.

The firm, best known as one of the world’s largest electronic market makers, has not publicly confirmed the exploration. But the talks, first surfaced through market sources on August 20, suggest Virtu is weighing whether its future looks leaner and more focused.

From acquisition to potential exit

The brokerage unit traces its roots primarily to Virtu’s March 2019 purchase of Investment Technology Group, better known as ITG. That deal cost approximately $1B.

ITG brought agency execution services, workflow technology, and analytics tools into Virtu’s orbit. The idea at the time was diversification: Virtu wanted to be more than just the firm that makes fractions of a penny on millions of trades per day. It wanted to offer institutional clients a broader suite of services.

Advertisement
window.sevioads = window.sevioads || []; var sevioads_preferences = []; sevioads_preferences[0] = {}; sevioads_preferences[0].zone = "de1434f5-fa9e-44a6-93c3-4c2439763717"; sevioads_preferences[0].adType = "banner"; sevioads_preferences[0].inventoryId = "c5700508-581b-472c-8fdd-a931cdbfc8e1"; sevioads_preferences[0].accountId = "1e47efc1-ec2d-4fca-a8b9-354e249e5095"; sevioads.push(sevioads_preferences);

A sale at the reported valuation range would mean Virtu roughly quadrupled the value of what it paid for the ITG business, assuming the brokerage unit’s worth is largely attributable to that acquisition.

No specific buyers have been named. No timeline for a deal has been floated. This is, by all indications, still in the preliminary exploration phase.

Why now

Virtu’s core market-making operation has been performing well. In Q1 2026, the company posted a normalized adjusted EPS of $2.24, up sharply from $1.30 in the prior year period.

Virtu has also been active on other fronts recently, launching a notional order execution tool designed for corporate buyback programs and initiating routine stock sales under Rule 144.

Shedding the brokerage unit would free up management attention and capital. A $3.5B-plus cash infusion could be redeployed into strengthening Virtu’s market-making infrastructure, pursuing share buybacks, or simply sitting on the balance sheet as dry powder for future opportunities.

What this means for the sector

For potential acquirers, the brokerage unit represents a turnkey agency execution platform with institutional relationships, analytics capabilities, and workflow technology that took years to build. Banks, alternative trading systems, and larger brokerage firms could all be logical buyers. Private equity firms with financial services portfolios might also circle.

The competitive dynamics in agency execution have intensified considerably since 2019. Firms like Instinet, Liquidnet, and various bank-owned platforms all compete for institutional order flow.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

US bank stocks sound the alarm! AI impact and the shadow of interest rate hikes loom, "death cross" reappears, indicating a possible prolonged decline

After experiencing their worst four-day losing streak since April 2025, major U.S. bank stocks have fallen into a "Death Cross" technical pattern, signaling bearish momentum.

智通财经•2026/11/19 23:51

Potentially the Biggest Deal in the Biopharmaceutical Industry in Recent Years! Sanofi (SNY.US) Plans Major Acquisition; Insmed (INSM.US) Stock Surges Over 20%!

According to informed sources, Sanofi is evaluating the possibility of acquiring the American pharmaceutical company Insmed. With the appointment of a new CEO, the French pharmaceutical company is actively seeking its next blockbuster drug.

智通财经•2026/11/19 23:22

The largest IPO in history surged and then pulled back on its first day; S&P and Nvidia fell for six consecutive sessions; Dow Jones dropped below 50,000 points; gold fell another 3%.

The Philadelphia Semiconductor Index fell by 2.4%, with AMD plummeting 7.7% due to short selling and Nvidia dropping 3.3% to a 52-week low. Oracle declined 3%, hitting a one-year low during intraday trading. CoreWeave fell 6.1%. The 10-year U.S. Treasury yield decreased by 1.5 basis points. The U.S. Dollar Index rose 0.2%, reaching an 18-month high. Offshore RMB dropped to a one-month low, touching the 6.70 level. WTI crude oil rose 1.1%. Gold hit its lowest level since last September. Silver declined 3%. Bitcoin fell 2%, returning to its July lows.

华尔街见闻•2026/11/19 23:11